ChemicalBook > CAS DataBase List > WRG-28

WRG-28

Product Name
WRG-28
CAS No.
1913291-02-7
Chemical Name
WRG-28
Synonyms
WRG-28;WRG-28, 10 mM in DMSO;WRG-28 (DDR2 inhibitor WRG-28;N-Ethyl-4-[[(3-oxo-3H-phenoxazin-7-yl)oxy]methyl]benzenesulfonamide;Benzenesulfonamide, N-ethyl-4-[[(3-oxo-3H-phenoxazin-7-yl)oxy]methyl]-;WRG28,4T1 breast cancer cells,WRG-28,joint destruction,breast cancer,Discoidin Domain Receptor,BT549,CAFs,HEK293,Inhibitor,inhibit,rheumatoid arthritis,WRG 28
CBNumber
CB45848795
Molecular Formula
C21H18N2O5S
Formula Weight
410.44
MOL File
1913291-02-7.mol
More
Less

WRG-28 Property

Boiling point:
603.4±65.0 °C(Predicted)
Density 
1.38±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO: 15.62 mg/mL (38.06 mM)
pka
11.55±0.50(Predicted)
form 
Solid
color 
Pink to red
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-0078189
Product name
WRG-28
Purity
99.42%
Packaging
5mg
Price
$150
Updated
2021/12/16
ChemScene
Product number
CS-0078189
Product name
WRG-28
Purity
99.42%
Packaging
10mg
Price
$250
Updated
2021/12/16
ChemScene
Product number
CS-0078189
Product name
WRG-28
Purity
99.42%
Packaging
25mg
Price
$550
Updated
2021/12/16
ChemScene
Product number
CS-0078189
Product name
WRG-28
Purity
99.42%
Packaging
50mg
Price
$950
Updated
2021/12/16
ChemScene
Product number
CS-0078189
Product name
WRG-28
Purity
99.42%
Packaging
100mg
Price
$1650
Updated
2021/12/16
More
Less

WRG-28 Chemical Properties,Usage,Production

Uses

WRG-28 is a selective, extracellularly acting DDR2 allosteric inhibitor, with an IC50 of 230 nM. WRG-28 inhibits tumor invasion, migration and tumor-supporting effects of cancer-associated fibroblasts (CAFs). WRG-28 inhibits metastatic breast tumor cell colonization in the lungs. WRG-28 also shows good activity of relieving rheumatoid arthritis in CAIA model of mice[1][2].

Biological Activity

WRG-28 is a potent, selective and extracellularly acting allosteric inhibitor of discoidin domain receptor 2 (DDR2) th at potently inhibits invasion and migration in mice model of breast cancer. WRG-28 inhibits metastatic breast tumor cell colonization in the lungs.

in vivo

WRG-28 (10 mg/kg; i.v.; single) attenuates biochemical signaling of DDR2 in breast tumors in vivo[1].
WRG-28 (10 mg/kg; i.v.; single daily for 7 days) reduces metastatic lung colonization of breast tumor cells[1].
WRG-28 (10 mg/kg; i.v.; single daily for 21 days) decreases both the inflammatory reaction and joint destruction in mice with collagen antibody-induced arthritis (CAIA)[2].

Animal Model:Female BALB/cJ mice (8-week-old; 4T1-Snail-CBG tumor-bearing mice model)[1].
Dosage:10 mg/kg
Administration:Intravenous injection, single.
Result:Reduced 60% SNAIL1-clic beetle green (SNAIL1.CBG) level within the tumor in mice.
Animal Model:Female BALB/cJ mice (8-week-old; injected with 4T1 GFP-luc expressing cells)[1].
Dosage:10 mg/kg
Administration:Intravenous injection, single daily for 7 days.
Result:Reduced lung colonization to a level comparable to shDDR2-depleted cells.
Animal Model:Male DBA/1 mice (8-week-old; CAIA model)[2].
Dosage:10 mg/kg
Administration:Intravenous injection, single daily for 21 days.
Result:Significantly ameliorated arthritis in the mice (reduced production of IL-15 and Dkk-1), the hind- paw thickness of the mice was also reduced.
Inhibited inflammatory cell infiltration and destruction of cartilage in mouse ankle and serum.
Significantly alleviated bone destruction, reduced the extent of joint space enlargement and bone mineral density, as well as decreased the severity of bone loss.

IC 50

DDR2: 230 nM (IC50)

References

[1] Grither WR, et al. Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain. Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7786-E7794. DOI:10.1073/pnas.1805020115
[2] Mu N, et al. Blockade of Discoidin Domain Receptor 2 as a Strategy for Reducing Inflammation and Joint Destruction in Rheumatoid Arthritis Via Altered Interleukin-15 and Dkk-1 Signaling in Fibroblast-Like Synoviocytes. Arthritis Rheumatol. 2020 Jun;72(6):943-956. DOI:10.1002/art.41205

WRG-28 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

WRG-28 Suppliers

Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Shanghai Rechem science Co., Ltd.
Tel
021-31433387 15618786686
Fax
QQ:1369748377
Email
sales@rechemscience.com
Country
China
ProdList
2989
Advantage
58
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
010-50973130 18101056239
Email
3193328036@qq.com
Country
China
ProdList
29760
Advantage
68
Tianjin heowns Biochemical Technology Co., Ltd.
Tel
400-6387771-6039 18920764717
Email
sales@heowns.com
Country
China
ProdList
23771
Advantage
60
Shenzhen GeneSeqTools Bioscience & Technology Co. Ltd.
Tel
0755-23251735 13302967066
Email
sales@geneseqtools.com
Country
China
ProdList
1420
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel
86-571-88216897,88216896 13588875226
Fax
86-571-88216895
Email
sales@hzclap.com
Country
CHINA
ProdList
6312
Advantage
58
Shanghai Star Pharmaceutical Chemical Technology Co., Ltd.
Tel
021-58521787 17701827760
Email
starpharmsh@gmail.com
Country
China
ProdList
292
Advantage
58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Fax
QQ 3610331285
Email
sales@chemegen.com
Country
China
ProdList
11218
Advantage
58
Shanghai hongqu biomedical technology co. LTD
Tel
88888888888
Email
hongquchem@qq.com
Country
China
ProdList
5132
Advantage
58

1913291-02-7, WRG-28Related Search:


  • WRG-28
  • Benzenesulfonamide, N-ethyl-4-[[(3-oxo-3H-phenoxazin-7-yl)oxy]methyl]-
  • WRG28,4T1 breast cancer cells,WRG-28,joint destruction,breast cancer,Discoidin Domain Receptor,BT549,CAFs,HEK293,Inhibitor,inhibit,rheumatoid arthritis,WRG 28
  • WRG-28, 10 mM in DMSO
  • WRG-28 (DDR2 inhibitor WRG-28
  • N-Ethyl-4-[[(3-oxo-3H-phenoxazin-7-yl)oxy]methyl]benzenesulfonamide
  • 1913291-02-7